J
John A. Ridge
Researcher at Fox Chase Cancer Center
Publications - 241
Citations - 21969
John A. Ridge is an academic researcher from Fox Chase Cancer Center. The author has contributed to research in topics: Cancer & Head and neck cancer. The author has an hindex of 57, co-authored 235 publications receiving 18883 citations. Previous affiliations of John A. Ridge include Temple University & Case Western Reserve University.
Papers
More filters
Journal ArticleDOI
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
Arlene A. Forastiere,Helmuth Goepfert,Moshe H. Maor,Thomas F. Pajak,Randal S. Weber,William H. Morrison,Bonnie S. Glisson,Andy Trotti,John A. Ridge,C. Chao,Glen Peters,Ding Jen Lee,Andrea Leaf,John F. Ensley,Jay S. Cooper +14 more
TL;DR: In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for larynGEal preservation and locoregional control.
Journal ArticleDOI
Improved Survival of Patients With Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
Carole Fakhry,William H. Westra,S. Li,Anthony J. Cmelak,John A. Ridge,Harlan A. Pinto,Arlene A. Forastiere,Maura L. Gillison +7 more
TL;DR: For patients with HNSCC of the oropharynx, tumor HPV status is strongly associated with therapeutic response and survival and, after adjustment for age, tumor stage, and ECOG performance status, lower risks of progression and death are found.
Journal ArticleDOI
A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
Karen K. Fu,Thomas F. Pajak,Andy Trotti,Christopher U. Jones,Sharon A. Spencer,Theodore L. Phillips,Adam S. Garden,John A. Ridge,Jay S. Cooper,K. Kian Ang +9 more
TL;DR: Hyperfractionation and accelerated fractionation with concomitant boost are more efficacious than standard fractionation for locally advanced head and neck cancer.
Journal ArticleDOI
Head and Neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
William M. Lydiatt,Snehal G. Patel,Brian O'Sullivan,Margaret S. Brandwein,John A. Ridge,Jocelyn C. Migliacci,Ashley Loomis,Jatin P. Shah +7 more
TL;DR: AJCC's 8th edition of the Staging manual, Head and Neck Section, introduced significant modifications from the prior 7th edition as discussed by the authors, including the reorganization of skin cancer (other than melanoma and Merkel cell carcinoma) from a general chapter for the entire body to a head and neck-specific cutaneous malignancies chapter; division of cancer of the pharynx into 3 separate chapters; changes to the tumor (T) categories for oral cavity, skin, and nasopharynx; and the addition of extranodal cancer extension to lymph
Journal ArticleDOI
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
Arlene A. Forastiere,Qiang Zhang,Randal S. Weber,Moshe H. Maor,Helmuth Goepfert,Thomas F. Pajak,William H. Morrison,Bonnie S. Glisson,Andy Trotti,John A. Ridge,Wade L. Thorstad,Henry N. Wagner,John F. Ensley,Jay S. Cooper +13 more
TL;DR: These 10-year results show that induction PF followed by RT and concomitant cisplatin/RT show similar efficacy for the composite end point of LFS, and new strategies that improve organ preservation and function with less morbidity are needed.